| pubmed-article:19967539 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19967539 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19967539 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:19967539 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:19967539 | lifeskim:mentions | umls-concept:C0920317 | lld:lifeskim |
| pubmed-article:19967539 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
| pubmed-article:19967539 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:19967539 | lifeskim:mentions | umls-concept:C1176020 | lld:lifeskim |
| pubmed-article:19967539 | lifeskim:mentions | umls-concept:C2349179 | lld:lifeskim |
| pubmed-article:19967539 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
| pubmed-article:19967539 | lifeskim:mentions | umls-concept:C1709518 | lld:lifeskim |
| pubmed-article:19967539 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19967539 | pubmed:dateCreated | 2010-5-18 | lld:pubmed |
| pubmed-article:19967539 | pubmed:abstractText | In this pharmacokinetic/pharmacodynamic meta-analysis, we investigated relationships between clinical endpoints and sunitinib exposure in patients with advanced solid tumors, including patients with gastrointestinal stromal tumor (GIST) and metastatic renal cell carcinoma (mRCC). | lld:pubmed |
| pubmed-article:19967539 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19967539 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19967539 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19967539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19967539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19967539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19967539 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19967539 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19967539 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:19967539 | pubmed:issn | 1432-0843 | lld:pubmed |
| pubmed-article:19967539 | pubmed:author | pubmed-author:MotzerRobert... | lld:pubmed |
| pubmed-article:19967539 | pubmed:author | pubmed-author:DemetriGeorge... | lld:pubmed |
| pubmed-article:19967539 | pubmed:author | pubmed-author:RosenLee SLS | lld:pubmed |
| pubmed-article:19967539 | pubmed:author | pubmed-author:BelloCarlo... | lld:pubmed |
| pubmed-article:19967539 | pubmed:author | pubmed-author:PolandBillB | lld:pubmed |
| pubmed-article:19967539 | pubmed:author | pubmed-author:HoukBrett EBE | lld:pubmed |
| pubmed-article:19967539 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19967539 | pubmed:volume | 66 | lld:pubmed |
| pubmed-article:19967539 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19967539 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19967539 | pubmed:pagination | 357-71 | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:meshHeading | pubmed-meshheading:19967539... | lld:pubmed |
| pubmed-article:19967539 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19967539 | pubmed:articleTitle | Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis. | lld:pubmed |
| pubmed-article:19967539 | pubmed:affiliation | Pfizer Inc., Global Research and Development, 10578 Science Center Drive, CB1, San Diego, CA 92121, USA. brett.houk@pfizer.com | lld:pubmed |
| pubmed-article:19967539 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19967539 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:19967539 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:19967539 | pubmed:publicationType | Meta-Analysis | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19967539 | lld:pubmed |
